Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Entero Healthcare Solutions Ltd (ENTERO) Share Price & Fundamentals

Company Overview

Founded Year

2018

Listed Year

2024

Headquarter

Mumbai, India

MD/CEO

Prabhat Agrawal

Website

https://www.enterohealthcare.com

Company Facts

What we do

Entero Healthcare Solutions Ltd is a leading pan-India technology-driven healthcare products distributor serving pharmacies, hospitals, and clinics with integrated supply chain solutions.

Founded in

2,018

Market share

Among top three healthcare distributors in India by revenue; rapidly expanding through acquisitions and market consolidation.

Problem solved

Solves fragmented pharma distribution inefficiencies by offering organized, tech-enabled, pan-India healthcare product distribution and demand generation.

Top clients or who we serve

Serves 95,300+ retail pharmacies, 3,600+ hospitals across India; B2B focus with strong ties to pharma manufacturers and hospitals.

Key management

Prabhat Agrawal (MD & CEO, IIT/IIM alumnus), Prem Sethi (Whole-time Director & COO) with strong healthcare sector experience.

Our journey and innovations

Founded 2018; IPO raised INR 1600 Cr in 2024; grew SKUs to 80,600+; expanded infrastructure to 101 warehouses; completed 51 acquisitions.

Where we operate

Operates across 21 states and 505 districts in India with 131 warehouses serving 50+ cities.

Top products or what we offer

Healthcare products distribution including pharmaceuticals, OTC, medical devices, nutraceuticals, surgical consumables, vaccines.

Top brands

Distributes top Indian pharmaceutical companies' products; also offers private labels and strategic hospital partnerships.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly from recurring sales and supply chain services; acquisition driven growth supports scale.

Our industry position

Key player benefiting from pharmaceutical distribution market consolidation with integrated tech platform and strong brand relationships.

Financial highlights

FY25 consolidated revenue INR 5,096 Cr, PAT INR 1074 million, EBITDA margin around 3.4%, consistent growth YoY.

Geographical revenue split

Revenue primarily from India with pan-India distribution; growing reach in urban and semi-urban markets.

Order book

-

Whats driving growth

Growth driven by market consolidation, acquisitions, expanded product portfolio, warehouse network, and technology adoption.

Our future plans

Focus on expanding medtech segment, further acquisitions, enhancing tech platforms and deepening hospital and retail reach.

Our green promise

-

Our people and values

Strong leadership with healthcare sector experience; commitment to employee stock ownership and corporate governance.

Key challenges ahead

Integrating numerous acquisitions, improving margins, managing working capital, and navigating regulatory environment.

Interesting facts

Fastest scale-up distributor in India with over 50 acquisitions; largest SKU portfolio and warehouse network among peers.

Risks and strategy

Mitigates market fragmentation risk via acquisitions; leverages technology; focuses on operational efficiency and compliance.

Market Footprint

Top Clients

Top Clients

Serves 95,300+ retail pharmacies, 3,600+ hospitals across India; B2B focus with strong ties to pharma manufacturers and hospitals.

Top Products

Top Products

Healthcare products distribution including pharmaceuticals, OTC, medical devices, nutraceuticals, surgical consumables, vaccines.

Price Movement & Share Holding

Today's High/Low

15511608.9

52 Week High/Low

9441920
Past Returns

1 week

7.66%

1 month

-10.68%

3 month

29.39%

1 year

43.81%

3 year

39.1%

5 year

39.1%

Share Holding

Promoters

52.4%

FII

5.77%

DII

21.16%

Retail

15.13%

Others

5.53%

Company Overview

Founded Year

2018

Listed Year

2024

Headquarter

Mumbai, India

MD/CEO

Prabhat Agrawal (MD & CEO

Website

https://www.enterohealthcare.com

Price Movement & Share Holding

Today's High/Low

15511608.9

52 Week High/Low

9441920

Past Returns

1 week

7.66%

1 month

-10.68%

3 month

29.39%

1 year

43.81%

3 year

39.1%

5 year

39.1%

Share Holding

Promoters

52.4%

FII

5.77%

DII

21.16%

Retail

15.13%

Others

5.53%

Company Facts

What we do

Entero Healthcare Solutions Ltd is a leading pan-India technology-driven healthcare products distributor serving pharmacies, hospitals, and clinics with integrated supply chain solutions.

Founded in

2018

Market share

Among top three healthcare distributors in India by revenue; rapidly expanding through acquisitions and market consolidation.

Problem solved

Solves fragmented pharma distribution inefficiencies by offering organized, tech-enabled, pan-India healthcare product distribution and demand generation.

Top clients or who we serve

Serves 95,300+ retail pharmacies, 3,600+ hospitals across India; B2B focus with strong ties to pharma manufacturers and hospitals.

Key management

Prabhat Agrawal (MD & CEO, IIT/IIM alumnus), Prem Sethi (Whole-time Director & COO) with strong healthcare sector experience.

Our journey and innovations

Founded 2018; IPO raised INR 1600 Cr in 2024; grew SKUs to 80,600+; expanded infrastructure to 101 warehouses; completed 51 acquisitions.

Where we operate

Operates across 21 states and 505 districts in India with 131 warehouses serving 50+ cities.

Top products or what we offer

Healthcare products distribution including pharmaceuticals, OTC, medical devices, nutraceuticals, surgical consumables, vaccines.

Top brands

Distributes top Indian pharmaceutical companies' products; also offers private labels and strategic hospital partnerships.

Recurring vs cyclical contribution

Revenue mainly from recurring sales and supply chain services; acquisition driven growth supports scale.

Our industry position

Key player benefiting from pharmaceutical distribution market consolidation with integrated tech platform and strong brand relationships.

Financial highlights

FY25 consolidated revenue INR 5,096 Cr, PAT INR 1074 million, EBITDA margin around 3.4%, consistent growth YoY.

Geographical revenue split

Revenue primarily from India with pan-India distribution; growing reach in urban and semi-urban markets.

Whats driving growth

Growth driven by market consolidation, acquisitions, expanded product portfolio, warehouse network, and technology adoption.

Our future plans

Focus on expanding medtech segment, further acquisitions, enhancing tech platforms and deepening hospital and retail reach.

Our people and values

Strong leadership with healthcare sector experience; commitment to employee stock ownership and corporate governance.

Key challenges ahead

Integrating numerous acquisitions, improving margins, managing working capital, and navigating regulatory environment.

Interesting facts

Fastest scale-up distributor in India with over 50 acquisitions; largest SKU portfolio and warehouse network among peers.

Risks and strategy

Mitigates market fragmentation risk via acquisitions; leverages technology; focuses on operational efficiency and compliance.

Market Footprint

Top Clients

Top Clients

Serves 95,300+ retail pharmacies, 3,600+ hospitals across India; B2B focus with strong ties to pharma manufacturers and hospitals.

Top Products

Top Products

Healthcare products distribution including pharmaceuticals, OTC, medical devices, nutraceuticals, surgical consumables, vaccines.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions